Your browser doesn't support javascript.
loading
SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy.
Kawanami, Daiji; Matoba, Keiichiro; Takeda, Yusuke; Nagai, Yosuke; Akamine, Tomoyo; Yokota, Tamotsu; Sango, Kazunori; Utsunomiya, Kazunori.
Affiliation
  • Kawanami D; Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan. daijika@jikei.ac.jp.
  • Matoba K; Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan. matoba@jikei.ac.jp.
  • Takeda Y; Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan. ms05-takeda@jikei.ac.jp.
  • Nagai Y; Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan. y.nagai@jikei.ac.jp.
  • Akamine T; Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan. akamine-tm@igakuken.or.jp.
  • Yokota T; Diabetic Neuropathy Project, Department of Sensory and Motor Systems, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan. akamine-tm@igakuken.or.jp.
  • Sango K; Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, Jikei University School of Medicine, 3-25-8 Nishi-shinbashi, Minato-ku, Tokyo 105-8461, Japan. yokotat@jikei.ac.jp.
  • Utsunomiya K; Diabetic Neuropathy Project, Department of Sensory and Motor Systems, Tokyo Metropolitan Institute of Medical Science, 2-1-6 Kamikitazawa, Setagaya-ku, Tokyo 156-8506, Japan. sango-kz@igakuken.or.jp.
Int J Mol Sci ; 18(5)2017 May 18.
Article in En | MEDLINE | ID: mdl-28524098

Full text: 1 Database: MEDLINE Main subject: Diabetic Nephropathies / Sodium-Glucose Transporter 2 / Sodium-Glucose Transporter 2 Inhibitors Type of study: Clinical_trials / Prognostic_studies Limits: Animals / Humans Language: En Year: 2017 Type: Article

Full text: 1 Database: MEDLINE Main subject: Diabetic Nephropathies / Sodium-Glucose Transporter 2 / Sodium-Glucose Transporter 2 Inhibitors Type of study: Clinical_trials / Prognostic_studies Limits: Animals / Humans Language: En Year: 2017 Type: Article